Low Cost LoRaWAN Image Acquisition System for Low Rate Internet of Things Applications

This paper proposes a low cost LoRaWAN image acquisition and transmission prototype for low rate and un-constrained delay IoT applications. Real scenario tests were performed and images, at distances up to 2.5 km from node to gateway in urban environment, were transmitted and correctly decoded. The obtained results show the effectiveness of a low-power wide-area (LPWAN) technology prototype for long distance image transmission in applications without delay constraints and where other wireless technologies are not available.This work has been funded by national funds through FCT - Fundacao para a Ciencia e a Tecnologia, I.P., under the Projects UIDB/05567/2020 and UIDP/05567/2020info:eu-repo/semantics/publishedVersio

VITASENIOR-MT: A distributed and scalable cloud-based telehealth solution

VITASENIOR-MT is a telehealth platform that allows to remotely monitor biometric and environmental data in a domestic environment, designed specifically to the elderly population. This paper proposes a highly scalable and efficient architecture to transport, process, store and visualize the data collected by devices of an Internet of Things (IoT) scenario. The cloud infrastructure follows a microservices architecture to provide computational scalability, better fault isolation, easy integration and automatic deployment. This solution is complemented with a pre-processing and validation of the collected data at the edge of the Internet by using the Fog Computing concept, allowing a better computing distribution. The presented approach provides personal data security and a simplified way to collect and present the data to the different actors, allowing a dynamic and intuitive management of patients and equipment to caregivers. The presented load tests proved that this solution is more efficient than a monolithic approach, promoting better access and control in the data flowing from heterogeneous equipment.This work has been financially supported by the IC&DT project VITASENIOR-MT CENTRO-01-0145- FEDER-023659 with FEDER funding through programs CENTRO2020 and FCT.info:eu-repo/semantics/publishedVersio

Emotionally-relevant features for classification and regression of music lyrics

This research addresses the role of lyrics in the music emotion recognition process. Our approach is based on several state of the art features complemented by novel stylistic, structural and semantic features. To evaluate our approach, we created a ground truth dataset containing 180 song lyrics, according to Russell’s emotion model. We conduct four types of experiments: regression and classification by quadrant, arousal and valence categories. Comparing to the state of the art features (ngrams - baseline), adding other features, including novel features, improved the F-measure from 69.9%, 82.7% and 85.6% to 80.1%, 88.3% and 90%, respectively for the three classification experiments. To study the relation between features and emotions (quadrants) we performed experiments to identify the best features that allow to describe and discriminate each quadrant. To further validate these experiments, we built a validation set comprising 771 lyrics extracted from the AllMusic platform, having achieved 73.6% F-measure in the classification by quadrants. We also conducted experiments to identify interpretable rules that show the relation between features and emotions and the relation among features. Regarding regression, results show that, comparing to similar studies for audio, we achieve a similar performance for arousal and a much better performance for valence

Usability of a telehealth solution based on TV interaction for the elderly: the VITASENIOR-MT case study

Remote monitoring of biometric data in the elderly population is an important asset for improving the quality of life and level of independence of elderly people living alone. However, the design and implementation of health technological solutions often disregard the elderly physiological and psychological abilities, leading to low adoption of these technologies. We evaluate the usability of a remote patient monitoring solution, VITASENIOR-MT, which is based on the interaction with a television set. Twenty senior participants (over 64 years) and a control group of 20 participants underwent systematic tests with the health platform and assessed its usability through several questionnaires. Elderly participants scored high on the usability of the platform, very close to the evaluation of the control group. Sensory, motor and cognitive limitations were the issues that most contributed to the difference in usability assessment between the elderly group and the control group. The solution showed high usability and acceptance regardless of age, digital literacy, education and impairments (sensory, motor and cognitive), which shows its effective viability for use and implementation as a consumer product in the senior market.This work has been financially supported by the Portuguese foundation for science and technology (FCT) and European funds through Project VITASENIOR-MT with grant CENTRO-01-0145-FEDER-023659.info:eu-repo/semantics/publishedVersio

O papel da inovação tecnológica e da ciência aberta no desenvolvimento sustentável das cidades e regiões – Um caso prático

info:eu-repo/semantics/publishedVersio

VITASENIOR–MT: Architecture of a Telehealth Solution

This poster was awarded the Best Poster Award at the Portuguese Conference Gestão & Tecnologi@ - Criação de Valor em Saúde.VITASENIOR-MT is a telehealth solution under development that aims to monitor and improve the healthcare of elderly people living in the region of Médio Tejo. This solution performs both remote and local monitoring of biometric parameters of the elderly, and also of environmental parameters of their homes. The biometric variables include heart rate and temperature measurements collected automatically, by means of a bracelet, throughout the day. Blood pressure, body weight, and other biometric parameters are measured on a daily basis by the senior’s own initiative, and automatically recorded. The environmental parameters include temperature, carbon monoxide and carbon dioxide measurements. A TV set is used as a mean of interaction between the user and the medical devices. The TV set is also used to receive medical warnings and recommendations according to clinical profiles, and to receive environmental alerts. All data and alerts can be accessible to senior’s family and healthcare providers. In alarm situations, an automatic operational procedure will be triggered establishing communication to predefined entities.This work has been financially supported by the IC&DT project VITASENIOR-MT Programa operacional regional do centro CENTRO-01-0145-FEDER-023659.info:eu-repo/semantics/publishedVersio

Inteligência para a Sustentabilidade das Cidades

info:eu-repo/semantics/publishedVersio

VITASENIOR-MT: a telehealth solution for the elderly focused on the interaction with TV

Remote monitoring of health parameters is a promising approach to improve the health condition and quality of life of particular groups of the population, which can also alleviate the current expenditure and demands of healthcare systems. The elderly, usually affected by chronic comorbidities, are a specific group of the population that can strongly benefit from telehealth technologies, allowing them to reach a more independent life, by living longer in their own homes. Usability of telehealth technologies and their acceptance by end-users are essential requirements for the success of telehealth implementation. Older people are resistant to new technologies or have difficulty in using them due to vision, hearing, sensory and cognition impairments. In this paper, we describe the implementation of an IoT-based telehealth solution designed specifically to address the elderly needs. The end-user interacts with a TV-set to record biometric parameters, and to receive warning and recommendations related to health and environmental sensor recordings. The familiarization of older people with the TV is expected to provide a more user-friendly interaction ensuring the effectiveness integration of the end-user in the overall telehealth solution.This work has been financially supported by the IC&DT project VITASENIOR-MT CENTRO-01-0145-FEDER- 023659 with FEDER funding through programs CENTRO2020 and FCT.info:eu-repo/semantics/publishedVersio

Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019

Background Disability and mortality burden of non-communicable diseases (NCDs) have risen worldwide; however, the NCD burden among adolescents remains poorly described in the EU. Methods Estimates were retrieved from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. Causes of NCDs were analysed at three different levels of the GBD 2019 hierarchy, for which mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) were extracted. Estimates, with the 95% uncertainty intervals (UI), were retrieved for EU Member States from 1990 to 2019, three age subgroups (10–14 years, 15–19 years, and 20–24 years), and by sex. Spearman's correlation was conducted between DALY rates for NCDs and the Socio-demographic Index (SDI) of each EU Member State. Findings In 2019, NCDs accounted for 86·4% (95% uncertainty interval 83·5–88·8) of all YLDs and 38·8% (37·4–39·8) of total deaths in adolescents aged 10–24 years. For NCDs in this age group, neoplasms were the leading causes of both mortality (4·01 [95% uncertainty interval 3·62–4·25] per 100 000 population) and YLLs (281·78 [254·25–298·92] per 100 000 population), whereas mental disorders were the leading cause for YLDs (2039·36 [1432·56–2773·47] per 100 000 population) and DALYs (2040·59 [1433·96–2774·62] per 100 000 population) in all EU Member States, and in all studied age groups. In 2019, among adolescents aged 10–24 years, males had a higher mortality rate per 100 000 population due to NCDs than females (11·66 [11·04–12·28] vs 7·89 [7·53–8·23]), whereas females presented a higher DALY rate per 100 000 population due to NCDs (8003·25 [5812·78–10 701·59] vs 6083·91 [4576·63–7857·92]). From 1990 to 2019, mortality rate due to NCDs in adolescents aged 10–24 years substantially decreased (–40·41% [–43·00 to –37·61), and also the YLL rate considerably decreased (–40·56% [–43·16 to –37·74]), except for mental disorders (which increased by 32·18% [1·67 to 66·49]), whereas the YLD rate increased slightly (1·44% [0·09 to 2·79]). Positive correlations were observed between DALY rates and SDIs for substance use disorders (rs=0·58, p=0·0012) and skin and subcutaneous diseases (rs=0·45, p=0·017), whereas negative correlations were found between DALY rates and SDIs for cardiovascular diseases (rs=–0·46, p=0·015), neoplasms (rs=–0·57, p=0·0015), and sense organ diseases (rs=–0·61, p=0·0005)

Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.

The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing cancer burden. To estimate cancer burden and trends globally for 204 countries and territories and by Sociodemographic Index (SDI) quintiles from 2010 to 2019. The GBD 2019 estimation methods were used to describe cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life years (DALYs) in 2019 and over the past decade. Estimates are also provided by quintiles of the SDI, a composite measure of educational attainment, income per capita, and total fertility rate for those younger than 25 years. Estimates include 95% uncertainty intervals (UIs). In 2019, there were an estimated 23.6 million (95% UI, 22.2-24.9 million) new cancer cases (17.2 million when excluding nonmelanoma skin cancer) and 10.0 million (95% UI, 9.36-10.6 million) cancer deaths globally, with an estimated 250 million (235-264 million) DALYs due to cancer. Since 2010, these represented a 26.3% (95% UI, 20.3%-32.3%) increase in new cases, a 20.9% (95% UI, 14.2%-27.6%) increase in deaths, and a 16.0% (95% UI, 9.3%-22.8%) increase in DALYs. Among 22 groups of diseases and injuries in the GBD 2019 study, cancer was second only to cardiovascular diseases for the number of deaths, years of life lost, and DALYs globally in 2019. Cancer burden differed across SDI quintiles. The proportion of years lived with disability that contributed to DALYs increased with SDI, ranging from 1.4% (1.1%-1.8%) in the low SDI quintile to 5.7% (4.2%-7.1%) in the high SDI quintile. While the high SDI quintile had the highest number of new cases in 2019, the middle SDI quintile had the highest number of cancer deaths and DALYs. From 2010 to 2019, the largest percentage increase in the numbers of cases and deaths occurred in the low and low-middle SDI quintiles. The results of this systematic analysis suggest that the global burden of cancer is substantial and growing, with burden differing by SDI. These results provide comprehensive and comparable estimates that can potentially inform efforts toward equitable cancer control around the world.Funding/Support: The Institute for Health Metrics and Evaluation received funding from the Bill & Melinda Gates Foundation and the American Lebanese Syrian Associated Charities. Dr Aljunid acknowledges the Department of Health Policy and Management of Kuwait University and the International Centre for Casemix and Clinical Coding, National University of Malaysia for the approval and support to participate in this research project. Dr Bhaskar acknowledges institutional support from the NSW Ministry of Health and NSW Health Pathology. Dr Bärnighausen was supported by the Alexander von Humboldt Foundation through the Alexander von Humboldt Professor award, which is funded by the German Federal Ministry of Education and Research. Dr Braithwaite acknowledges funding from the National Institutes of Health/ National Cancer Institute. Dr Conde acknowledges financial support from the European Research Council ERC Starting Grant agreement No 848325. Dr Costa acknowledges her grant (SFRH/BHD/110001/2015), received by Portuguese national funds through Fundação para a Ciência e Tecnologia, IP under the Norma Transitória grant DL57/2016/CP1334/CT0006. Dr Ghith acknowledges support from a grant from Novo Nordisk Foundation (NNF16OC0021856). Dr Glasbey is supported by a National Institute of Health Research Doctoral Research Fellowship. Dr Vivek Kumar Gupta acknowledges funding support from National Health and Medical Research Council Australia. Dr Haque thanks Jazan University, Saudi Arabia for providing access to the Saudi Digital Library for this research study. Drs Herteliu, Pana, and Ausloos are partially supported by a grant of the Romanian National Authority for Scientific Research and Innovation, CNDS-UEFISCDI, project number PN-III-P4-ID-PCCF-2016-0084. Dr Hugo received support from the Higher Education Improvement Coordination of the Brazilian Ministry of Education for a sabbatical period at the Institute for Health Metrics and Evaluation, between September 2019 and August 2020. Dr Sheikh Mohammed Shariful Islam acknowledges funding by a National Heart Foundation of Australia Fellowship and National Health and Medical Research Council Emerging Leadership Fellowship. Dr Jakovljevic acknowledges support through grant OI 175014 of the Ministry of Education Science and Technological Development of the Republic of Serbia. Dr Katikireddi acknowledges funding from a NHS Research Scotland Senior Clinical Fellowship (SCAF/15/02), the Medical Research Council (MC_UU_00022/2), and the Scottish Government Chief Scientist Office (SPHSU17). Dr Md Nuruzzaman Khan acknowledges the support of Jatiya Kabi Kazi Nazrul Islam University, Bangladesh. Dr Yun Jin Kim was supported by the Research Management Centre, Xiamen University Malaysia (XMUMRF/2020-C6/ITCM/0004). Dr Koulmane Laxminarayana acknowledges institutional support from Manipal Academy of Higher Education. Dr Landires is a member of the Sistema Nacional de Investigación, which is supported by Panama’s Secretaría Nacional de Ciencia, Tecnología e Innovación. Dr Loureiro was supported by national funds through Fundação para a Ciência e Tecnologia under the Scientific Employment Stimulus–Institutional Call (CEECINST/00049/2018). Dr Molokhia is supported by the National Institute for Health Research Biomedical Research Center at Guy’s and St Thomas’ National Health Service Foundation Trust and King’s College London. Dr Moosavi appreciates NIGEB's support. Dr Pati acknowledges support from the SIAN Institute, Association for Biodiversity Conservation & Research. Dr Rakovac acknowledges a grant from the government of the Russian Federation in the context of World Health Organization Noncommunicable Diseases Office. Dr Samy was supported by a fellowship from the Egyptian Fulbright Mission Program. Dr Sheikh acknowledges support from Health Data Research UK. Drs Adithi Shetty and Unnikrishnan acknowledge support given by Kasturba Medical College, Mangalore, Manipal Academy of Higher Education. Dr Pavanchand H. Shetty acknowledges Manipal Academy of Higher Education for their research support. Dr Diego Augusto Santos Silva was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil Finance Code 001 and is supported in part by CNPq (302028/2018-8). Dr Zhu acknowledges the Cancer Prevention and Research Institute of Texas grant RP210042